Foresee Genomics provides comprehensive next-generation sequencing (NGS) solutions, including protocols, reagents, and bioinformatics tools, to make high-accuracy genomic analysis accessible to smaller laboratories. Their technology enables labs to perform rapid, accurate diagnostics with minimal investment and small sample requirements. This accessibility accelerates timely genomic testing, supporting precision medicine and enhancing patient care outcomes.
Funding
$1.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Small and medium-sized laboratories face significant barriers to adopting next-generation sequencing (NGS) due to the high cost, extensive lab space requirements, and complexity of existing solutions. This limits their ability to perform advanced genomic analysis, hindering progress in diagnostics and precision medicine.
Solution
Foresee Genomics provides an integrated NGS platform designed for accessibility and efficiency, enabling smaller laboratories to conduct high-accuracy genomic analysis. The solution comprises optimized protocols, specialized reagents, and user-friendly bioinformatics tools, all engineered to minimize capital expenditure and laboratory footprint. By leveraging Nanopore sequencing technology and intelligent analysis software, Foresee Genomics empowers labs to deliver timely and precise diagnostic results. This facilitates enhanced patient care and opens new avenues for growth in the precision medicine sector.
Target Audience
The primary target audience includes small to medium-sized clinical diagnostic laboratories, research institutions, and contract research organizations seeking to implement or expand their NGS capabilities.
Features
- Comprehensive NGS workflow including sample preparation, library construction, and sequencing protocols.
- Proprietary reagent kits optimized for high yield and purity with minimal sample input.
- Integration with Nanopore sequencing technology for real-time data generation.
- Cloud-based bioinformatics pipeline for automated variant calling, annotation, and reporting.
- Modular software architecture allowing for customization of analysis parameters.
- User interface designed for ease of use, requiring minimal specialized bioinformatics expertise.
- Scalable infrastructure to accommodate varying sample throughput requirements.